Linezolid for the Treatment of Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus

被引：11
|
作者：
Wolff, Michel [1 ]
Mourvillier, Bruno [1 ]
机构：
[1] Univ Paris Diderot, Hop Bichat Claude Bernard, AP HP, Serv Reanimat Med & Malad Infect,Sorbonne Paris C, F-75877 Paris 18, France
来源：
CLINICAL INFECTIOUS DISEASES | 2012年 / 55卷 / 01期
关键词：
VANCOMYCIN;
D O I：
10.1093/cid/cis330
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [1] LINEZOLID VS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA DUE TO METHICILLIN-RESISTANT S AUREUS
    Takada, Hiroaki
    Hifumi, Toru
    Koido, Yuichi
    Kuroda, Yasuhiro
    Kato, Hiroshi
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [2] Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
    Wunderink, Richard G.
    Niederman, Michael S.
    Kollef, Marin H.
    Shorr, Andrew F.
    Kunkel, Mark J.
    Baruch, Alice
    McGee, William T.
    Reisman, Arlene
    Chastre, Jean
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (05) : 621 - 629
  • [3] Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Thamlikitkul, Visanu
    Tongsai, Sasima
    [J]. CHEST, 2012, 142 (01) : 269 - 270
  • [4] Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
    Powers, JH
    Ross, DB
    Lin, D
    Soreth, J
    [J]. CHEST, 2004, 126 (01) : 314 - 315
  • [5] Linezolid Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Controversy Continues
    Masuta, Kana
    Oba, Yuichiro
    Iwata, Kentaro
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 161 - 161
  • [6] Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic
    Lesher, Beth
    Gao, Xin
    Chen, Yixi
    Liu, Zhengyin
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 63 - 72
  • [7] Vancomycin Versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Implications of the ZEPHyR Trial
    Alaniz, Cesar
    Pogue, Jason M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (10) : 1432 - 1435
  • [8] Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan
    Lin, Po-Chang
    Wang, Bruce C. M.
    Kim, Richard
    Magyar, Andrew
    Lai, Chung-Chih
    Yang, Ya-Wen
    Huang, Yhu-Chering
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 46 - 51
  • [9] Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Segarra-Newnham, Marisel
    Church, Timothy J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1678 - 1687
  • [10] Alternative Treatment Options for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Pasquale, Timothy R.
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2016, 24 (02) : 67 - +
12345